BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 711497)

  • 1. Liver involvement in cystic fibrosis. A report of 9 cases.
    Schwarz HP; Kraemer R; Thurnheer U; Rossi E
    Helv Paediatr Acta; 1978 Nov; 33(4-5):351-64. PubMed ID: 711497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meconium ileus and its equivalent as a risk factor for the development of cirrhosis: an autopsy study in cystic fibrosis.
    Maurage C; Lenaerts C; Weber A; Brochu P; Yousef I; Roy CC
    J Pediatr Gastroenterol Nutr; 1989 Jul; 9(1):17-20. PubMed ID: 2778565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of liver disease in cystic fibrosis.
    Lindblad A; Glaumann H; Strandvik B
    Hepatology; 1999 Nov; 30(5):1151-8. PubMed ID: 10534335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatobiliary disease in cystic fibrosis patients with pancreatic sufficiency.
    Waters DL; Dorney SF; Gruca MA; Martin HC; Howman-Giles R; Kan AE; De Silva M; Gaskin KJ
    Hepatology; 1995 Apr; 21(4):963-9. PubMed ID: 7535738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver disease in cystic fibrosis.
    Colombo C; Apostolo MG; Assaisso M; Roman B; Bottani P
    Neth J Med; 1992 Oct; 41(3-4):119-22. PubMed ID: 1470280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of liver disease in cystic fibrosis: a longitudinal study.
    Lamireau T; Monnereau S; Martin S; Marcotte JE; Winnock M; Alvarez F
    J Hepatol; 2004 Dec; 41(6):920-5. PubMed ID: 15582124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome.
    Colombo C; Battezzati PM; Crosignani A; Morabito A; Costantini D; Padoan R; Giunta A
    Hepatology; 2002 Dec; 36(6):1374-82. PubMed ID: 12447862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver disease in children with cystic fibrosis.
    Diwakar V; Pearson L; Beath S
    Paediatr Respir Rev; 2001 Dec; 2(4):340-9. PubMed ID: 12052306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolated hepatic transplant in patient with cystic fibrosis].
    Berenguer M; Prieto M; Orbis F; Morales P; Mir J; Berenguer J
    Gastroenterol Hepatol; 1996; 19(7):356-8. PubMed ID: 8963905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial Splenic Embolization: successful treatment of hypersplenism, secondary to biliary cirrhosis and portal hypertension in cystic fibrosis.
    Aslanidou E; Fotoulaki M; Tsitouridis I; Nousia-Arvanitakis S
    J Cyst Fibros; 2007 May; 6(3):212-4. PubMed ID: 17157565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis: its influence on the liver, biliary tree, and bile salt metabolism.
    Isenberg JN
    Semin Liver Dis; 1982 Nov; 2(4):302-13. PubMed ID: 6763343
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgical considerations in cystic fibrosis: a 32-year evaluation of outcomes.
    Escobar MA; Grosfeld JL; Burdick JJ; Powell RL; Jay CL; Wait AD; West KW; Billmire DF; Scherer LR; Engum SA; Rouse TM; Ladd AP; Rescorla FJ
    Surgery; 2005 Oct; 138(4):560-71; discussion 571-2. PubMed ID: 16269283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory immunoglobulin A (sIgA) in the serum of cystic fibrosis patients.
    Hein J; Schober S; Seyfarth M; Brock J; Kirschnick HD
    Wien Klin Wochenschr; 1988 Jan; 100(2):57-9. PubMed ID: 3348043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.
    Smith JL; Lewindon PJ; Hoskins AC; Pereira TN; Setchell KD; O'Connell NC; Shepherd RW; Ramm GA
    Hepatology; 2004 Jun; 39(6):1673-82. PubMed ID: 15185309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute metabolic alkalosis in cystic fibrosis: prospective study and review of the literature.
    Mauri S; Pedroli G; Rüdeberg A; Laux-End R; Monotti R; Bianchetti MG
    Miner Electrolyte Metab; 1997; 23(1):33-7. PubMed ID: 9058367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neonatal obstructive jaundice revealing mucoviscisosis].
    Raynaud EJ; Hennequet A; Menut G; Lavignon A; Malpuech G; Lagarde R
    Ann Pediatr (Paris); 1972 Feb; 19(2):145-51. PubMed ID: 5053188
    [No Abstract]   [Full Text] [Related]  

  • 17. Cystic fibrosis manifested as focal biliary cirrhosis in a newborn infant with congenital heart disease.
    Cooper HS; Oppenheimer EH
    Johns Hopkins Med J; 1974 Oct; 135(4):268-73. PubMed ID: 4412693
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis.
    Kinnman N; Lindblad A; Housset C; Buentke E; Scheynius A; Strandvik B; Hultcrantz R
    Hepatology; 2000 Aug; 32(2):334-40. PubMed ID: 10915740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Liver complications in patients with mucoviscidosis].
    Gyurkovits K; Szabó A
    Orv Hetil; 1984 Feb; 125(8):437-41. PubMed ID: 6700984
    [No Abstract]   [Full Text] [Related]  

  • 20. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
    Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.